BioSpace News Archive

Business

binx health Appoints Life Sciences Veteran Jack Crowley as Chief Financial Officer

binx health , a healthcare technology and diagnostics company, announced today the appointment of Jack Crowley as Chief Financial Officer (CFO).

April 5, 2022
·
2 min read
Drug Development

VBI Vaccines Announces New Data and Progress of VBI-2900, VBI’s eVLP Coronavirus Program

VBI Vaccines Inc. today announced updated clinical and preclinical data from its coronavirus program, VBI-2900.

April 5, 2022
·
8 min read
Biotech Bay

Cutera Announces First Patient Treated with FDA Cleared AviClear™ Acne Device

CUTERA, INC. today announced that the first patient outside of clinical trials was treated with AviClear, the only device cleared by the FDA for the treatment of mild, moderate, and severe acne.

April 5, 2022
·
3 min read
Drug Development

Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for the Treatment of Gastroparesis

Processa Pharmaceuticals, Inc. announced today that it has enrolled its first patient in the Phase 2A clinical trial of PCS12852 in patients with moderate to severe gastroparesis.

April 5, 2022
·
4 min read
Drug Development

Allergan, an AbbVie Company, Announces Positive Topline Phase 3 Results Evaluating Investigational Twice-Daily Administration of VUITY™ (pilocarpine HCI ophthalmic solution) 1.25% in Adults with Age-Related Blurry Near Vision (Presbyopia)

Allergan, an AbbVie (NYSE: ABBV) company, today announced that the Phase 3 VIRGO trial evaluating the safety and efficacy of investigational twice-daily administration of VUITY.

April 5, 2022
·
7 min read
Multi-center Clinical Study Data on Anaconda Biomed’s Mechanical Thrombectomy System Published in Stroke

Multi-center Clinical Study Data on Anaconda Biomed’s Mechanical Thrombectomy System Published in Stroke.

April 5, 2022
·
3 min read
Business

Twist Bioscience and Ginkgo Bioworks Sign New Collaboration

Twist Bioscience Corporation and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a new supply agreement expanding the depth and breadth of the collaboration between two of the leading organizations in the synthetic biology ecosystem.

April 5, 2022
·
7 min read
Bio NC

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 05, 2022

BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted 19 newly-hired employees stock options to purchase an aggregate of 124,800 shares, and restricted stock units covering an aggregate of 47,400 shares, of BioCryst common stock.

April 5, 2022
·
1 min read
Drug Development

Pharma Two B Presents Late-Breaker Abstract on Positive Efficacy and Safety Data of P2B001 from Phase 3 Trial at American Academy of Neurology (AAN) Annual Meeting

Pharma Two B Ltd today announced that the efficacy and safety data from its recently completed Phase 3, randomized controlled trial of P2B001 in the management of early Parkinson’s disease is being presented today, April 5th.

April 5, 2022
·
6 min read
Business

MindMed Appoints Francois Lilienthal, MD as Chief Commercial Officer

Mind Medicine today announced the appointment of Francois Lilienthal, MD as Chief Commercial Officer.

April 5, 2022
·
3 min read